Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Clasificación en acciones #31189
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Precio por acción
$0.03808538
Capitalización bursátil
$14.04M
Cambio (1 día)
-3.57%
Cambio (1 año)
6.63%
País
AU
Comercio BCAL Diagnostics Limited (BDX)

Categoría

Ratio P/S de BCAL Diagnostics Limited (BDX)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de BCAL Diagnostics Limited, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de BCAL Diagnostics Limited desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US